We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.48%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.62B
AUM Growth
-$84.4M
Cap. Flow
-$358M
Cap. Flow %
-9.89%
Top 10 Hldgs %
26.83%
Holding
5,773
New
537
Increased
1,570
Reduced
3,043
Closed
580

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$46.2M
2
MSFT icon
Microsoft
MSFT
+$46.2M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$40M
4
NVDA icon
NVIDIA
NVDA
+$27.6M
5
PLTR icon
Palantir
PLTR
+$27.6M

Sector Composition

Rank Sector Weight
1 Technology 17.33%
2 Financials 7.48%
3 Consumer Discretionary 6.48%
4 Healthcare 6.28%
5 Communication Services 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBNK icon
3651
Capital Bancorp
CBNK
$613M
$13.8K ﹤0.01%
433
-664
-61% -$22.2K
RCMT icon
3652
RCM Technologies
RCMT
$248M
$13.8K ﹤0.01%
520
+515
+10,300% +$13.2K
AB icon
3653
AllianceBernstein
AB
$3.41B
$13.8K ﹤0.01%
361
+237
+191% +$9.48K
IHRT icon
3654
iHeartMedia
IHRT
$457M
$13.8K ﹤0.01%
4,803
-19,539
-80% -$43.2K
REPX icon
3655
Riley Exploration Permian
REPX
$800M
$13.8K ﹤0.01%
508
-714
-58% -$19.5K
FF icon
3656
Future Fuel
FF
$245M
$13.8K ﹤0.01%
3,546
-909
-20% -$3.59K
BEEP icon
3657
Mobile Infrastructure Corp
BEEP
$107M
$13.7K ﹤0.01%
3,906
+3,896
+38,960% +$14.8K
VABK icon
3658
Virginia National Bankshares
VABK
$254M
$13.7K ﹤0.01%
354
-1,219
-77% -$47.3K
ALLO icon
3659
Allogene Therapeutics
ALLO
$708M
$13.7K ﹤0.01%
11,055
-6,539
-37% -$7.8K
LCNB icon
3660
LCNB Corp
LCNB
$283M
$13.7K ﹤0.01%
914
-2,889
-76% -$44.6K
KRO icon
3661
KRONOS Worldwide
KRO
$975M
$13.7K ﹤0.01%
2,386
-1,327
-36% -$8.04K
AURA icon
3662
Aura Biosciences
AURA
$795M
$13.7K ﹤0.01%
2,216
-4,156
-65% -$27.2K
TVRD
3663
Tvardi Therapeutics
TVRD
$23.7M
$13.7K ﹤0.01%
351
+248
+241% +$7.06K
INMB icon
3664
INmune Bio
INMB
$60.2M
$13.7K ﹤0.01%
6,604
+4,303
+187% +$9.85K
PKBK icon
3665
Parke Bancorp
PKBK
$413M
$13.7K ﹤0.01%
634
-716
-53% -$15.5K
CDLX icon
3666
Cardlytics
CDLX
$24.9M
$13.6K ﹤0.01%
561
-96
-15% -$1.6K
ACU icon
3667
Acme United Corp
ACU
$232M
$13.6K ﹤0.01%
331
+327
+8,175% +$13.8K
EFSI
3668
Eagle Financial Services Inc
EFSI
$236M
$13.6K ﹤0.01%
+360
New +$12.7K
RMBI icon
3669
Richmond Mutual Bancorp
RMBI
$255M
$13.6K ﹤0.01%
958
+799
+503% +$11.4K
EPM icon
3670
Evolution Petroleum
EPM
$135M
$13.6K ﹤0.01%
2,821
-5,440
-66% -$27.1K
MGPI icon
3671
MGP Ingredients
MGPI
$379M
$13.6K ﹤0.01%
561
-1,322
-70% -$38.3K
HFFG icon
3672
HF Foods Group
HFFG
$99.2M
$13.5K ﹤0.01%
4,906
-7,544
-61% -$24.1K
HURC icon
3673
Hurco Companies Inc
HURC
$146M
$13.5K ﹤0.01%
+777
New +$14.4K
ATOM icon
3674
Atomera
ATOM
$219M
$13.5K ﹤0.01%
3,056
+2,138
+233% +$8.78K
IMCR icon
3675
Immunocore
IMCR
$1.74B
$13.5K ﹤0.01%
+371
New +$12.6K

Similar funds

Tower Research Capital (TRC)'s Q3 2025 Portfolio in Review

As of Q3 2025, Tower Research Capital (TRC) held 5,773 positions worth $3.62B, down 2.3% from $3.71B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) withdrew a net $358M in Q3 2025, closing 580 positions and reducing 3,043 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $23.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in JPMorgan Ultra-Short Income ETF worth $30.6M.

  • Tower Research Capital (TRC)'s largest Q3 2025 buy was JPMorgan Ultra-Short Income ETF: 603,010 shares worth $30.6M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2025, an estimated $254M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2025 reduction was Apple, cutting an estimated $46.2M.
  • Tower Research Capital (TRC) fully exited Vanguard S&P 500 ETF in Q3 2025, selling an estimated $23.6M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $3.62B portfolio in Q3 2025.
  • Tower Research Capital (TRC) opened 537 new positions and closed 580 in Q3 2025.
  • Tower Research Capital (TRC)'s portfolio value fell 2.3% quarter-over-quarter to $3.62B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2025, filed 14 Nov 2025.